RWS Group

RWS is a world-leading provider of technology-enabled language, content, and intellectual property services. The company operates through four main divisions: Language Services, Regulated Industries (including Life Sciences), IP Services, and Language & Content Technology. It is a critical partner for the global pharmaceutical and biotechnology sectors, providing essential services for clinical trials and regulatory compliance. In the life sciences sector, RWS specializes in linguistic validation of Clinical Outcomes Assessments (COAs), translation of New Drug Applications (NDAs) and Marketing Authorization Applications (MAAs), and the management of complex multilingual labeling and packaging. The company has increasingly pivoted toward AI-driven solutions, launching platforms like TrainAI and Etheos to automate and enhance the accuracy of large-scale content localization.